Ferrando F - Search Results

1

Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone.

Réganon E, Ferrando F, Vila V, Villa P, Martínez-Sales V, Fayos L, Ruano M, Aznar J. Réganon E, et al. Among authors: ferrando f. Haemostasis. 1998 Mar-Apr;28(2):99-105. doi: 10.1159/000022419. Haemostasis. 1998. PMID: 10087435 Clinical Trial.

2

Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.

Martínez-Sales V, Vila V, Réganon E, Goberna MA, Ferrando F, Palencia MA, Aznar J. Martínez-Sales V, et al. Among authors: ferrando f. Haemostasis. 1998 Nov-Dec;28(6):301-6. doi: 10.1159/000022446. Haemostasis. 1998. PMID: 10461012 Clinical Trial.

3

Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis.

Villa P, Aznar J, Vaya A, España F, Ferrando F, Mira Y, Estellés A. Villa P, et al. Among authors: ferrando f. Thromb Haemost. 1999 Sep;82(3):1011-4. Thromb Haemost. 1999. PMID: 10494755

4

Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.

Reganon E, Vila V, Ferrando F, Martínez-Sales V, Fayos L, Ruano M, Aznar J. Reganon E, et al. Among authors: ferrando f. Thromb Haemost. 1999 Nov;82(5):1403-5. Thromb Haemost. 1999. PMID: 10595627

5

Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk.

Medina P, Navarro S, Estellés A, Vayá A, Woodhams B, Mira Y, Villa P, Migaud-Fressart M, Ferrando F, Aznar J, Bertina RM, España F. Medina P, et al. Among authors: ferrando f. Thromb Haemost. 2004 May;91(5):905-11. doi: 10.1160/TH03-10-0657. Thromb Haemost. 2004. PMID: 15116250

6

Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke.

Aznar J, Mira Y, Vayá A, Corella D, Ferrando F, Villa P, Estellés A. Aznar J, et al. Among authors: ferrando f. Thromb Haemost. 2004 May;91(5):1031-4. doi: 10.1160/TH03-11-0690. Thromb Haemost. 2004. PMID: 15116266

7

Sialic acid is an inflammation marker associated with a history of deep vein thrombosis.

Reganon E, Vila V, Martínez-Sales V, Vayá A, Mira Y, Ferrando F, Aznar J. Reganon E, et al. Among authors: ferrando f. Thromb Res. 2007;119(1):73-8. doi: 10.1016/j.thromres.2005.12.017. Epub 2006 Feb 28. Thromb Res. 2007. PMID: 16500696

8

Hemorheological alterations and hypercoagulable state in deep vein thrombosis.

Mira Y, Vayá A, Martínez M, Villa P, Santaolaria ML, Ferrando F, Aznar J. Mira Y, et al. Among authors: ferrando f. Clin Hemorheol Microcirc. 1998 Dec;19(4):265-70. Clin Hemorheol Microcirc. 1998. PMID: 9972663

9

PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.

Seguí R, Estellés A, Mira Y, España F, Villa P, Falcó C, Vayá A, Grancha S, Ferrando F, Aznar J. Seguí R, et al. Among authors: ferrando f. Br J Haematol. 2000 Oct;111(1):122-8. doi: 10.1046/j.1365-2141.2000.02321.x. Br J Haematol. 2000. PMID: 11091191 Free article.

10

Implementation of SintromacWeb(R), a new internet-based tool for oral anticoagulation therapy telecontrol: Study on system consistency and patient satisfaction.

Ferrando F, Mira Y, Contreras MT, Aguado C, Aznar JA. Ferrando F, et al. Thromb Haemost. 2010 May;103(5):1091-101. doi: 10.1160/TH09-07-0469. Epub 2010 Apr 13. Thromb Haemost. 2010. PMID: 20390224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters